Clinical Trial Detail

NCT ID NCT03913026
Title UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Ciusss de L'Est de l'Ile de Montreal
Indications

acute myeloid leukemia

myelodysplastic syndrome

acute lymphoblastic leukemia

Therapies

ECT-001 cord blood cells

Mycophenolate mofetil

Tacrolimus

Cyclophosphamide + Fludarabine

Cyclophosphamide + Fludarabine + Thiotepa

Age Groups: adult senior

Additional content available in CKB BOOST